Clinical Trial Update: Atazanavir/Ritonavir and Darunavir/Ritonavir PK Tail Study [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic tail study of fixed-dose combinations atazanavir/ritonavir and darunavir/ritonavir in HIV infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• EVOTAZ (atazanavir/ritonavir) (atazanavir/ritonavir)
• Prezcobix (darunavir/ritonavir) (darunavir/ritonavir)

Snippet

Sponsor: St Stephens Aids Trust | Conditions: HIV, HIV Infections | Phase 1 | Status: COMPLETED